MannKind Corp. (MNKD)
2.54
+0.09
(+3.67%)
USD |
NASDAQ |
Apr 01, 16:00
2.55
+0.01
(+0.39%)
After-Hours: 20:00
MannKind Research and Development Expense (TTM) : 66.35M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| United Therapeutics Corp. | 550.00M |
| Amicus Therapeutics, Inc. | 135.84M |
| Keros Therapeutics, Inc. | 129.56M |
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Ionis Pharmaceuticals, Inc. | 914.12M |